| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 15, 2026 |
Alumis Inc.
ALMS
|
BUY |
$39.00
Est. +64%
|
$23.82 | $24.72 |
Pending
|
$24.15
+1.4%
|
| May 13, 2026 |
Legend Biotech Corp - ADR
LEGN
|
BUY |
$48.00
Est. +74%
|
$27.56 | $37.46 |
Pending
|
$35.48
+28.7%
|
| May 13, 2026 |
Biohaven Ltd
BHVN
|
BUY |
$18.00
Est. +102%
|
$8.93 | $12.22 |
Pending
|
$12.14
+35.9%
|
| May 07, 2026 |
United Therapeutics Corp
UTHR
|
SELL |
$516.00
Est. +12%
|
$583.15 | $534.97 (Low) |
Pending
|
$549.57
+5.8%
|
| May 01, 2026 |
Merck & Co Inc
MRK
|
SELL |
$112.00
Est. +0%
|
$112.47 | $110.75 (Low) |
Precision Hit (±3%)
|
$114.90
-2.2%
|
| Apr 30, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$788.00
Est. +12%
|
$703.18 | $730.59 |
Pending
|
$614.65
-12.6%
|
| Apr 10, 2026 |
AMGEN Inc.
AMGN
|
SELL |
$326.00
Est. +8%
|
$352.59 | $320.53 (Low) |
Precision Hit (±3%)
|
$350.53
+0.6%
|
| Apr 10, 2026 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$63.00
Est. +31%
|
$47.98 | $56.50 |
Pending
|
$54.27
+13.1%
|
| Apr 10, 2026 |
United Therapeutics Corp
UTHR
|
SELL |
$519.00
Est. +9%
|
$570.48 | $534.97 (Low) |
Pending
|
$549.57
+3.7%
|
| Apr 10, 2026 |
BioNTech SE - ADR
BNTX
|
BUY |
$126.00
Est. +35%
|
$93.38 | $113.12 |
Pending
|
$90.80
-2.8%
|
| Mar 17, 2026 |
Pfizer Inc.
PFE
|
SELL |
$27.00
Est. +0%
|
$27.06 | $25.19 (Low) |
Target Met
|
$26.00
+3.9%
|
| Mar 05, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,313.00
Est. +35%
|
$972.50 | $1,182.73 |
Pending
|
$1,129.59
+16.2%
|
| Feb 13, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$570.00
Est. +15%
|
$497.42 | $507.92 |
Pending
|
$450.69
-9.4%
|
| Feb 12, 2026 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$61.00
Est. +36%
|
$44.71 | $56.50 |
Pending
|
$54.27
+21.4%
|
| Feb 08, 2026 |
Biogen Inc
BIIB
|
SELL |
$190.00
Est. +6%
|
$201.18 | $168.64 (Low) |
Target Met
|
$198.64
+1.3%
|
| Feb 06, 2026 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$40.00
Est. +35%
|
$61.86 | $54.20 (Low) |
Pending
|
$56.24
+9.1%
|
| Feb 01, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$769.00
Est. +4%
|
$741.45 | $815.00 |
Target Met
|
$614.65
-17.1%
|
| Jan 22, 2026 |
Johnson & Johnson
JNJ
|
SELL |
$200.00
Est. +9%
|
$220.37 | $217.84 (Low) |
Pending
|
$235.66
-6.9%
|
| Dec 12, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$768.00
Est. +4%
|
$741.52 | $821.11 |
Target Met
|
$614.65
-17.1%
|
| Dec 12, 2025 |
Biogen Inc
BIIB
|
SELL |
$156.00
Est. +10%
|
$173.90 | $160.36 (Low) |
Precision Hit (±3%)
|
$198.64
-14.2%
|
| Dec 12, 2025 |
Structure Therapeutics Inc - ADR
GPCR
|
BUY |
$125.00
Est. +89%
|
$66.24 | $94.77 |
Pending
|
$42.93
-35.2%
|
| Dec 03, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$516.00
Est. +19%
|
$433.15 | $507.92 |
Precision Hit (±3%)
|
$450.69
+4.0%
|
| Nov 24, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,290.00
Est. +22%
|
$1,059.70 | $1,182.73 |
Pending
|
$1,129.59
+6.6%
|
| Nov 03, 2025 |
Merck & Co Inc
MRK
|
BUY |
$100.00
Est. +18%
|
$84.65 | $125.14 |
Target Met
|
$114.90
+35.7%
|
| Oct 31, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$147.00
Est. +24%
|
$118.52 | $157.27 |
Target Met
|
$124.30
+4.9%
|
| Oct 15, 2025 |
Johnson & Johnson
JNJ
|
SELL |
$190.00
Est. +0%
|
$190.85 | $184.66 (Low) |
Precision Hit (±3%)
|
$235.66
-23.5%
|
| Oct 10, 2025 |
BioNTech SE - ADR
BNTX
|
BUY |
$131.00
Est. +25%
|
$104.48 | $124.00 |
Pending
|
$90.80
-13.1%
|
| Oct 10, 2025 |
United Therapeutics Corp
UTHR
|
SELL |
$435.00
Est. +2%
|
$445.38 | $409.03 (Low) |
Target Met
|
$549.57
-23.4%
|
| Aug 08, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$143.00
Est. +20%
|
$119.41 | $157.27 |
Target Met
|
$124.30
+4.1%
|
| Jul 15, 2025 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$16.00
Est. +26%
|
$12.69 | $22.50 |
Target Met
|
$17.04
+34.3%
|
| Jul 10, 2025 |
Merck & Co Inc
MRK
|
BUY |
$98.00
Est. +16%
|
$84.39 | $125.14 |
Target Met
|
$114.90
+36.2%
|
| Jul 10, 2025 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$54.00
Est. +49%
|
$36.14 | $56.50 |
Target Met
|
$54.27
+50.2%
|
| Jul 10, 2025 |
BioNTech SE - ADR
BNTX
|
BUY |
$133.00
Est. +18%
|
$112.26 | $124.00 |
Pending
|
$90.80
-19.1%
|
| Jul 10, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$754.00
Est. +35%
|
$560.28 | $821.11 |
Target Met
|
$614.65
+9.7%
|
| Jun 18, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$135.00
Est. +25%
|
$108.00 | $157.27 |
Target Met
|
$124.30
+15.1%
|
| Jun 02, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$755.00
Est. +54%
|
$490.81 | $821.11 |
Target Met
|
$614.65
+25.2%
|
| May 05, 2025 |
Organon & Co.
OGN
|
BUY |
$10.00
Est. +15%
|
$8.72 | $13.39 |
Target Met
|
$13.44
+54.1%
|
| Mar 11, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$130.00
Est. +14%
|
$114.43 | $157.27 |
Target Met
|
$124.30
+8.6%
|
| Feb 05, 2025 |
Merck & Co Inc
MRK
|
BUY |
$106.00
Est. +17%
|
$90.74 | $122.43 |
Target Met
|
$114.90
+26.6%
|
| Feb 03, 2025 |
Nurix Therapeutics Inc
NRIX
|
SELL |
$17.00
Est. +10%
|
$18.95 | $8.18 (Low) |
Target Met
|
$17.04
+10.1%
|
| Jan 10, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$456.00
Est. +11%
|
$409.56 | $519.68 |
Target Met
|
$450.69
+10.0%
|
| Oct 31, 2024 |
Biogen Inc
BIIB
|
BUY |
$204.00
Est. +13%
|
$181.18 | $179.48 |
Miss
|
$198.64
+9.6%
|
| Oct 21, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$319.00
Est. +1%
|
$316.74 | $335.88 |
Target Met
|
$350.53
+10.7%
|
| Oct 18, 2024 |
Gilead Sciences, Inc.
GILD
|
SELL |
$84.00
Est. +4%
|
$87.07 | $85.61 (Low) |
Precision Hit (±3%)
|
$124.30
-42.8%
|
| Oct 16, 2024 |
Johnson & Johnson
JNJ
|
BUY |
$175.00
Est. +7%
|
$164.10 | $194.40 |
Target Met
|
$235.66
+43.6%
|
| Sep 23, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$145.00
Est. +28%
|
$113.05 | $129.27 |
Miss
|
$90.80
-19.7%
|
| Sep 23, 2024 |
Structure Therapeutics Inc - ADR
GPCR
|
BUY |
$118.00
Est. +181%
|
$41.92 | $45.37 |
Miss
|
$42.93
+2.4%
|
| Sep 12, 2024 |
Gilead Sciences, Inc.
GILD
|
SELL |
$79.00
Est. +4%
|
$82.63 | $81.57 (Low) |
Miss
|
$124.30
-50.4%
|
| Aug 27, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,106.00
Est. +16%
|
$957.51 | $972.48 |
Miss
|
$1,129.59
+18.0%
|
| Aug 06, 2024 |
AMGEN Inc.
AMGN
|
SELL |
$303.00
Est. +8%
|
$330.79 | $257.05 (Low) |
Target Met
|
$350.53
-6.0%
|
| Aug 05, 2024 |
BioNTech SE - ADR
BNTX
|
BUY |
$93.00
Est. +19%
|
$78.36 | $131.49 |
Target Met
|
$90.80
+15.9%
|
| Jul 24, 2024 |
Biohaven Ltd
BHVN
|
BUY |
$58.00
Est. +53%
|
$37.81 | $55.58 |
Miss
|
$12.14
-67.9%
|
| Jul 11, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,182.00
Est. +10%
|
$1,071.12 | $1,211.20 |
Precision Hit (±3%)
|
$614.65
-42.6%
|
| Jul 11, 2024 |
Biogen Inc
BIIB
|
BUY |
$311.00
Est. +34%
|
$232.75 | $237.98 |
Miss
|
$198.64
-14.7%
|
| Jul 11, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,083.00
Est. +15%
|
$939.78 | $972.53 |
Miss
|
$1,129.59
+20.2%
|
| Jul 11, 2024 |
Royalty Pharma plc - Ordinary Shares - Class A
RPRX
|
BUY |
$51.00
Est. +98%
|
$25.73 | $36.56 |
Miss
|
$54.27
+110.9%
|
| Jul 02, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,023.00
Est. +13%
|
$906.15 | $972.53 |
Miss
|
$1,129.59
+24.7%
|
| May 03, 2024 |
AMGEN Inc.
AMGN
|
SELL |
$310.00
Est. +2%
|
$315.19 | $257.05 (Low) |
Target Met
|
$350.53
-11.2%
|
| Mar 27, 2024 |
Johnson & Johnson
JNJ
|
BUY |
$169.00
Est. +8%
|
$155.77 | $169.99 |
Bullseye Hit (±1%)
|
$235.66
+51.3%
|
| Nov 27, 2023 |
Pfizer Inc.
PFE
|
BUY |
$37.00
Est. +21%
|
$30.50 | $31.54 |
Miss
|
$26.00
-14.8%
|
| Aug 09, 2023 |
Lilly(Eli) & Co
LLY
|
BUY |
$617.00
Est. +17%
|
$526.40 | $966.10 |
Target Met
|
$1,129.59
+114.6%
|
| Jul 14, 2022 |
Abbvie Inc
ABBV
|
BUY |
$191.00
Est. +26%
|
$152.15 | - | - |
$221.59
+45.6%
|
| May 03, 2022 |
Abbvie Inc
ABBV
|
BUY |
$188.00
Est. +27%
|
$147.87 | - | - |
$221.59
+49.9%
|
| Apr 11, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$364.00
Est. +18%
|
$308.96 | - | - |
$1,129.59
+265.6%
|
| Apr 11, 2022 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$64.00
Est. +16%
|
$76.50 | - | - |
$56.24
+26.5%
|
| Apr 11, 2022 |
Merck & Co Inc
MRK
|
SELL |
$80.00
Est. +8%
|
$86.63 | - | - |
$114.90
-32.6%
|
| Apr 06, 2022 |
Abbvie Inc
ABBV
|
BUY |
$192.00
Est. +14%
|
$168.91 | - | - |
$221.59
+31.2%
|